Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

Ozempic and Rybelsus both treat diabetes and cause weight loss, but Ozempic is an injection and Rybelsus is a pill.

Fake fat jab sellers' warning from health minister who tells the Mirror dodgy weight loss injections can cause life ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

Updated versions of best-selling drugs may mitigate some of the impact of patent cliff losses, but strategy is key in a ...

Doctors explain how effective the first GLP-1 weight loss pill is, as well as its side effects, where to get it, and how much ...

There's now a prescription GLP-1 pill for weight loss on the market. Here are six key things to know about it.

Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...

A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo Nordisk rolled out the first GLP-1 ...

The world’s first GLP-1 weight loss treatment is being administered for pets on an experimental basis. The first cat was successfully dosed in the MEOW-1 study of OKV-119 – an investigational ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...